These results stimulated Burlot et al. [66] to explore the effect of AAV delivery of CYP46A1 to the hippocampus of a mouse model of AD-like Tau pathology, with low levels of hippocampal 24S-HC. This evidence concerns the gene CYP46A1 and Alzheimer disease.